194 related articles for article (PubMed ID: 38892648)
1. Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems.
Ye X; Fung NSK; Lam WC; Lo ACY
Nutrients; 2024 May; 16(11):. PubMed ID: 38892648
[TBL] [Abstract][Full Text] [Related]
2. Nutraceuticals for the Treatment of Diabetic Retinopathy.
Rossino MG; Casini G
Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987058
[TBL] [Abstract][Full Text] [Related]
3. Current trends in the pharmacotherapy of diabetic retinopathy.
Kumar B; Gupta SK; Saxena R; Srivastava S
J Postgrad Med; 2012; 58(2):132-9. PubMed ID: 22718058
[TBL] [Abstract][Full Text] [Related]
4. Role of Oral Antioxidant Supplementation in the Current Management of Diabetic Retinopathy.
Alfonso-Muñoz EA; Burggraaf-Sánchez de Las Matas R; Mataix Boronat J; Molina Martín JC; Desco C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924714
[TBL] [Abstract][Full Text] [Related]
5. The Evolving Treatment of Diabetic Retinopathy.
Mansour SE; Browning DJ; Wong K; Flynn HW; Bhavsar AR
Clin Ophthalmol; 2020; 14():653-678. PubMed ID: 32184554
[TBL] [Abstract][Full Text] [Related]
6. Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review.
Milluzzo A; Barchitta M; Maugeri A; Magnano San Lio R; Favara G; Mazzone MG; Sciacca L; Agodi A
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297113
[TBL] [Abstract][Full Text] [Related]
7. Progress of Nanotechnology in Diabetic Retinopathy Treatment.
Liu Y; Wu N
Int J Nanomedicine; 2021; 16():1391-1403. PubMed ID: 33658779
[TBL] [Abstract][Full Text] [Related]
8. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
[TBL] [Abstract][Full Text] [Related]
9. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy.
Arrigo A; Aragona E; Bandello F
Ann Med; 2022 Dec; 54(1):1089-1111. PubMed ID: 35451900
[TBL] [Abstract][Full Text] [Related]
10. Novelties in Diabetic Retinopathy.
Ebneter A; Zinkernagel MS
Endocr Dev; 2016; 31():84-96. PubMed ID: 26824524
[TBL] [Abstract][Full Text] [Related]
11. Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review.
Gunawan M; Boonkanokwong V
Colloids Surf B Biointerfaces; 2024 Jan; 233():113608. PubMed ID: 37925866
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate for diabetic retinopathy.
Kataoka SY; Lois N; Kawano S; Kataoka Y; Inoue K; Watanabe N
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013318. PubMed ID: 37310870
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for diabetic retinopathy: Are we ready to make the leap from bench to bedside?
Wang JH; Ling D; Tu L; van Wijngaarden P; Dusting GJ; Liu GS
Pharmacol Ther; 2017 May; 173():1-18. PubMed ID: 28132907
[TBL] [Abstract][Full Text] [Related]
14. Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy.
Zeng L; Ma W; Shi L; Chen X; Wu R; Zhang Y; Chen H; Chen H
Int J Nanomedicine; 2019; 14():6357-6369. PubMed ID: 31496691
[TBL] [Abstract][Full Text] [Related]
15. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications.
Semeraro F; Morescalchi F; Cancarini A; Russo A; Rezzola S; Costagliola C
Diabetes Metab; 2019 Dec; 45(6):517-527. PubMed ID: 31005756
[TBL] [Abstract][Full Text] [Related]
16. Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.
Narayanan SP; Shosha E; D Palani C
Pharmacol Res; 2019 Sep; 147():104299. PubMed ID: 31207342
[TBL] [Abstract][Full Text] [Related]
17. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
[TBL] [Abstract][Full Text] [Related]
18. Novel drugs and their targets in the potential treatment of diabetic retinopathy.
Nawaz MI; Abouammoh M; Khan HA; Alhomida AS; Alfaran MF; Ola MS
Med Sci Monit; 2013 Apr; 19():300-8. PubMed ID: 23619778
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the treatment and delivery system of diabetic retinopathy.
Wang Z; Zhang N; Lin P; Xing Y; Yang N
Front Endocrinol (Lausanne); 2024; 15():1347864. PubMed ID: 38425757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
